Keiretsu Forum Mid-Atlantic, South-East, and Texas Regions Introduce New Due Diligence Team

FOR IMMEDIATE RELEASE
Contact: Cindi Sutera
CindiS@AMSCommunications.net
610-613-2773

 

Philadelphia, Pennsylvania (December 18, 2024)  – Keiretsu Forum Mid-Atlantic, South-East, and Texas (K4-MST) regions are pleased to introduce its new Due Diligence team. This experienced group will strengthen its commitment to delivering thorough due diligence and high-quality deal flow to investors. Known globally for its rigorous evaluation process, Keiretsu Forum supports informed decision-making for accredited investors, venture capitalists, and family office managers seeking early-stage investment opportunities.

The Due Diligence team brings deep industry knowledge and leadership experience, ensuring members access detailed assessments to evaluate risk and opportunity.

• Marie Marlow, Due Diligence Director: Marlow brings decades of C-level leadership in health care and med-tech. She is recognized for her strategic market access expertise and deep understanding of regulatory landscapes, including FDA processes.
• John Welsh: Welsh is a research scientist and entrepreneur with expertise in commercializing medical innovations. Welsh’s academic background includes advanced research at the University of Pennsylvania and Los Alamos National Laboratory.
• Eamon Gallagher: Gallagher, a Keiretsu Fellow Emeritus, evaluates early-stage opportunities using his combined expertise in law and entrepreneurship. He also directs the Center for Law and Transformational Technology at Drexel University, which connects innovators with legal strategies to support commercialization.
• Mohit Prajapati: Prajapati is a healthcare entrepreneur with a record of advancing early-stage med-tech companies from concept to commercialization. His experience includes derisking assumptions and aligning innovations to meet the needs of patients, providers, and payors.

The addition of this team highlights Keiretsu Forum’s unwavering focus on supporting investors with comprehensive evaluations of emerging opportunities.

“We are excited to welcome this outstanding team to lead our Due Diligence efforts,” said Howard Lubert, Regional President, K4-MST. “Their extensive industry knowledge, proven leadership, and commitment to critical analysis will provide our investors with a clear understanding of the risks and rewards in today’s market.”

About Keiretsu Forum
Keiretsu Forum is the world’s largest private equity angel investment network with 2000+ accredited investors in 35 North American and 23 International chapters, who have invested more than $1B in early-stage companies in the last 25 years. 

The Keiretsu Forum portfolio features Entrepreneurs and Companies from Technology-(Internet, Software, Cyber Security, SaaS, Mobile Systems, IoT, etc.), Life Sciences-(Pharma, Medical Devices, Health IT, etc.), FinServ/FinTech, Consumer Products, Clean-Green Energy, Consumer Products, & more!

 

###

---